hide message

Welcome to the Resource Centre

We make it our mission to work with advocates in civil society, business and government to address inequalities of power, seek remedy for abuse, and ensure protection of people and planet.

Both companies and impacted communities thank us for the resources and support we provide.

This is only possible because of your support. Please make a donation today.

Thank you,
Phil Bloomer, Executive Director

Donate now hide message

You are being redirected to the story the piece of content is found in so you can read it in context. Please click the following link if you are not automatically redirected within a couple seconds:

UNCTAD: Bundle Of Opportunities To Improve Medicines Access In LDCs

Author: Catherine Saez, Intellectual Property Watch [Switzerland], Published on: 9 May 2011

Access to essential medicines in least developed countries (LDCs) could be facilitated through local production, according to a report released today by the United Nations Conference on Trade and Development...[M]ajor players in developed countries[are] facing the expiration of patents on some high-revenue drugs, and a shortage of new drugs to replace them...pushing those companies to seek partnerships with prominent generic manufacturers both in developed and in developing countries...[S]ome caution needs to be exercised, the report said...“[I]nvestors will need assurances by governments” that the basic prerequisites for the manufacture of high-quality medicines at low cost are present in the countries...The choice of medicines to be produced locally... needs to follow a public health perspective...technology transfer needs to be part of any investment in the local production or pharmaceuticals...

Read the full post here